Axsome Therapeutics (NASDAQ:AXSM), a biopharmaceutical company focused on central nervous system (CNS) disorders, released its earnings on August 4, 2025. The company reported GAA ...

There’s set to be sheer terror in Coronation Street next week, when Tyrone Dobbs ( Alan Halsall) realises his son, Dorin Pop ...

As cases of blood toxicity from Vitamin B6 continue to rise doctors raise concerns about the level of the product in food and ...

A new survey has revealed the prevalence of migraines is far worse in Australian women than experts previously estimated.

Discover Axsome Therapeutics' Q2 2025 earnings highlights, including 72% revenue growth, new product launch SYMBRAVO, and promising neuroscience ...

Below, DailyMail.com details the five supplements you should avoid consuming with coffee: Regularly taking a Vitamin D supplement can help improve bone health, muscles and immune health and studies ...

Despite their bitter divorce in 1994, Burt Reynolds also once praised his ex-wife for sticking by him as he battled addiction ...

The McMigraine “hack” — which is really just a specific order from McDonald’s — is simple, calling for one large Coca-Cola ...

Appeals Court Affirms Denial of Disability Benefits to Indiana Man The U.S. Court of Appeals for the Seventh Circuit has ...

In March 2025, Dassault Systèmes made a strategic investment in Click Therapeutics to deepen its involvement in the digital therapeutics space. The move supports Dassault's broader goal of ...

Analysts estimate that Amgen will report an earnings per share (EPS) of $5.26. The announcement from Amgen is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...

Medical research has long established that women are two to three times more likely to experience migraines than men ...